Clinical Trial

A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

Name: A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes — clinical trial record (NCT07658560)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy of BGM0504 tablets compared with placebo in reducing body weight in overweight or obese participants without diabetes after 20 weeks of treatment.

Trial Details

NCT Number	NCT07658560
Lead Sponsor	BrightGene Bio-Medical Technology Co., Ltd.
Conditions	Overweight or Obese Participants Without Diabetes
Enrollment	200 participants
Start Date	2026-06-30
Primary Completion	2027-02-28 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-22